Voraxaze
Term · Oncology and biomedicine · MLC-T-ONC-009317
A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Voraxaze is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Voraxaze is a type of chemoprotective agent and a type of prodrug activator. Also called carboxypeptidase-G2 and glucarpidase.
| Identifier | MLC-T-ONC-009317 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | carboxypeptidase-G2; glucarpidase |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009317",
"term": "Voraxaze",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat toxic levels of the anticancer drug methotrexate in the blood of adults and children with kidney problems. Voraxaze is a bacterial enzyme that helps break down and remove methotrexate from the body. It may also help certain drugs kill cancer cells. Voraxaze is a type of chemoprotective agent and a type of prodrug activator. Also called carboxypeptidase-G2 and glucarpidase.",
"synonyms": [
"carboxypeptidase-G2",
"glucarpidase"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/voraxaze/"
}
Record 17,338 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.